Review and analysis of 2023 Clinical Guidelines for Lipid Metabolism Disorders
The novelty of the 2023 National Guidelines for Lipid Metabolism Disorders is presented regarding the categorization of cardiovascular risk, target and optimal levels of blood lipids, diagnosis and therapeutic approaches to the treatment of dyslipidemia.
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«FIRMA «SILICEA» LLC
2023-12-01
|
| Series: | Российский кардиологический журнал |
| Subjects: | |
| Online Access: | https://russjcardiol.elpub.ru/jour/article/view/5688 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850025483577589760 |
|---|---|
| author | I. V. Sergienko M. V. Ezhov |
| author_facet | I. V. Sergienko M. V. Ezhov |
| author_sort | I. V. Sergienko |
| collection | DOAJ |
| description | The novelty of the 2023 National Guidelines for Lipid Metabolism Disorders is presented regarding the categorization of cardiovascular risk, target and optimal levels of blood lipids, diagnosis and therapeutic approaches to the treatment of dyslipidemia. |
| format | Article |
| id | doaj-art-03a7cac463e04ac1a05c1becdea7484c |
| institution | DOAJ |
| issn | 1560-4071 2618-7620 |
| language | Russian |
| publishDate | 2023-12-01 |
| publisher | «FIRMA «SILICEA» LLC |
| record_format | Article |
| series | Российский кардиологический журнал |
| spelling | doaj-art-03a7cac463e04ac1a05c1becdea7484c2025-08-20T03:00:50Zrus«FIRMA «SILICEA» LLCРоссийский кардиологический журнал1560-40712618-76202023-12-01284S10.15829/1560-4071-2023-56883976Review and analysis of 2023 Clinical Guidelines for Lipid Metabolism DisordersI. V. Sergienko0M. V. Ezhov1E.I. Chazov National Medical Research Center of CardiologyE.I. Chazov National Medical Research Center of CardiologyThe novelty of the 2023 National Guidelines for Lipid Metabolism Disorders is presented regarding the categorization of cardiovascular risk, target and optimal levels of blood lipids, diagnosis and therapeutic approaches to the treatment of dyslipidemia.https://russjcardiol.elpub.ru/jour/article/view/5688lipid metabolism disordersdyslipidemiaatherosclerosislow-density lipoprotein cholesteroltriglycerideslipoprotein(a)inclisiranfenofibrate |
| spellingShingle | I. V. Sergienko M. V. Ezhov Review and analysis of 2023 Clinical Guidelines for Lipid Metabolism Disorders Российский кардиологический журнал lipid metabolism disorders dyslipidemia atherosclerosis low-density lipoprotein cholesterol triglycerides lipoprotein(a) inclisiran fenofibrate |
| title | Review and analysis of 2023 Clinical Guidelines for Lipid Metabolism Disorders |
| title_full | Review and analysis of 2023 Clinical Guidelines for Lipid Metabolism Disorders |
| title_fullStr | Review and analysis of 2023 Clinical Guidelines for Lipid Metabolism Disorders |
| title_full_unstemmed | Review and analysis of 2023 Clinical Guidelines for Lipid Metabolism Disorders |
| title_short | Review and analysis of 2023 Clinical Guidelines for Lipid Metabolism Disorders |
| title_sort | review and analysis of 2023 clinical guidelines for lipid metabolism disorders |
| topic | lipid metabolism disorders dyslipidemia atherosclerosis low-density lipoprotein cholesterol triglycerides lipoprotein(a) inclisiran fenofibrate |
| url | https://russjcardiol.elpub.ru/jour/article/view/5688 |
| work_keys_str_mv | AT ivsergienko reviewandanalysisof2023clinicalguidelinesforlipidmetabolismdisorders AT mvezhov reviewandanalysisof2023clinicalguidelinesforlipidmetabolismdisorders |